Doppelherz Pharma
- Company typePrivate
- Founded-
- HeadquartersFlensburg, Germany
- Headcount1–10
- GTM typeB2C
- OfferingHardware or Manufacturing
Doppelherz Pharma firmographics
Firmographics- Name
- Doppelherz Pharma
- Legal name
- Doppelherz Pharma GmbH
- Website
- https://doppelherzpharma.de
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Doppelherz Pharma industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)
- SIC
- Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)
- akta.pro secondary industry
- Specialty Care Pharmaceuticals (HLAIAAAB)
Keywords
Where Doppelherz Pharma is headquartered
LocationHeadquarters
- HQ city
- Flensburg
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Doppelherz Pharma business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Marketing or Sales, Personnel, Technology or R&D
Revenue model
- Pharmacy-only Medicines Sales: Doppelherz Pharma generates revenue through the sale of apothekenpflichtige (pharmacy-only) medicines, including chemically synthesized drugs and natural medicines. Sales are made exclusively through pharmacies, with distribution handled by parent company Queisser Pharma GmbH & Co. KG. Products are offered at attractive price-performance ratios.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Doppelherz Pharma product offering
Product offeringCore offering
Doppelherz Pharma GmbH manufactures a portfolio of pharmacy-only medicines (apothekenpflichtige Arzneimittel) featuring modern and proven active ingredients and dosage forms in high-demand therapeutic areas. The range focuses on chemically synthesized pharmaceuticals supplemented by select natural medicines. Products are sold exclusively through pharmacies in Germany at attractive price-performance ratios, with professional pharmacist consultation provided at point of sale. Distribution is handled by the parent company Queisser Pharma GmbH & Co. KG.
Product overview
Doppelherz Pharma GmbH operates as a subsidiary of Queisser Pharma GmbH & Co. KG, both headquartered in Flensburg, Germany. The company offers a portfolio of pharmacy-only medicines (apothekenpflichtige Arzneimittel) distributed exclusively through pharmacies. The product range focuses on chemically-synthesized drugs complemented by select natural remedies, covering high-demand therapeutic indications. Distribution is managed through the parent company Queisser Pharma GmbH & Co. KG.
Differentiator
Problem solved
Functional benefit
Products and services
- Doppelherz Pharma Arzneimittel (Pharmacy-Only Medicines) A portfolio of pharmacy-only medications (apothekenpflichtige Arzneimittel) featuring modern and well-established active ingredients and dosage forms in high-demand therapeutic areas. The focus is on chemically synthesized medicines supplemented by select natural remedies. Products are available exclusively through pharmacies in Germany at an attractive price-performance ratio, with professional pharmacist consultation provided at point of sale. Distribution is managed by parent company Queisser Pharma GmbH & Co. KG.
Companies that use Doppelherz Pharma
Customer profileSegments4 records
Ideal customer profiles2 records
Doppelherz Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration10 records
Doppelherz Pharma partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Queisser Pharma GmbH & Co. KGcoreDoppelherz Pharma GmbH is a subsidiary company of Queisser Pharma GmbH & Co. KG, both headquartered in Flensburg. Queisser Pharma handles the distribution and sales of Doppelherz Pharma products. Queisser Pharma is known as a manufacturer of high-quality dietary supplements, medical devices, and medicines with focus on traditional herbal remedies.
Scale indicators1 record
Recent moves4 records
Expansion highlights3 records
Doppelherz Pharma competitors and assessment
Company assessmentDirect peers
- Dermapharm Holding SE: German pharmaceutical company focused on branded pharmaceuticals and healthcare products sold predominantly through pharmacies; comparable in terms of product mix, German-only distribution, and pharmacy-led GTM.
- Hexal AG (Sandoz): Leading German generics and pharmaceutical manufacturer; sells chemically synthesized medicines through pharmacies in Germany with similar regulatory and channel dynamics as Doppelherz Pharma.
- Dr. Wolff Group: German family-owned manufacturer of pharmaceuticals, medical devices, and cosmetics distributed primarily through pharmacies; overlapping portfolio approach and pharmacy-channel focus make it a close comparable.
- Klosterfrau Melisana GmbH: German pharmaceutical manufacturer specializing in traditional and natural/herbal medicines distributed through pharmacies; particularly relevant to Doppelherz Pharma's natural-medicine component and parent Queisser's herbal focus.
- Stada Arzneimittel AG: German-headquartered pharmaceutical company specializing in generics and consumer health products sold primarily through pharmacies; directly comparable to Doppelherz Pharma's apothekenpflichtige, pharmacy-distributed model in Germany.
- Mibe GmbH Arzneimittel: Mid-sized German pharmaceutical manufacturer producing branded generics and OTC products for the pharmacy channel; similar scale, German market focus, and chemically-synthesized product orientation as Doppelherz Pharma.
- ratiopharm GmbH (Teva): German pharmacy-focused pharmaceutical company (Teva subsidiary) selling generic and established-molecule medicines through the Apotheke channel; closely comparable to Doppelherz Pharma's chemically synthesized, pharmacy-distributed portfolio.
Broad incumbents
- Bayer AG (Consumer Health): Global pharmaceutical giant with a large German pharmacy-distributed Consumer Health portfolio; broader and more diversified than Doppelherz Pharma but competes head-to-head in the same apothekenpflichtige categories.
- Sanofi-Aventis Deutschland GmbH: German arm of Sanofi with a substantial pharmacy-channel OTC and prescription portfolio; overlaps with Doppelherz Pharma in pharmacy-distributed chemically synthesized medicines at a much larger scale.
- Haleon plc (Consumer Healthcare): Global consumer healthcare company (formerly GSK Consumer Healthcare) with pharmacy-distributed OTC and self-care products across Germany; comparable end-channel and consumer-marketing approach, though with broader international reach.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Doppelherz Pharma social profiles
Digital presenceDoppelherz Pharma compliance and trust
Trust signalCompliance1 record
Doppelherz Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Doppelherz Pharma leadership team
Management profileNumber of profiles
Profiles2 records
Doppelherz Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Doppelherz Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Doppelherz Pharma
What does Doppelherz Pharma do?
Doppelherz Pharma GmbH manufactures a portfolio of pharmacy-only medicines (apothekenpflichtige Arzneimittel) featuring modern and proven active ingredients and dosage forms in high-demand therapeutic areas. The range focuses on chemically synthesized pharmaceuticals supplemented by select natural medicines. Products are sold exclusively through pharmacies in Germany at attractive price-performance ratios, with professional pharmacist consultation provided at point of sale. Distribution is handled by the parent company Queisser Pharma GmbH & Co. KG.
Is Doppelherz Pharma a public or private company?
Doppelherz Pharma is a private company. It is classified as corporate owned and is currently operating.
When was Doppelherz Pharma founded?
Doppelherz Pharma was founded in -1. It employs 1 to 10 people.
Where is Doppelherz Pharma based?
Doppelherz Pharma is headquartered in Flensburg, Germany, in the Europe region.
How does Doppelherz Pharma make money?
One revenue line is on record: pharmacy-only Medicines Sales.
Who are Doppelherz Pharma's main competitors?
Direct peers on record are Dermapharm Holding SE, Hexal AG (Sandoz), Dr. Wolff Group, Klosterfrau Melisana GmbH, Stada Arzneimittel AG, Mibe GmbH Arzneimittel and ratiopharm GmbH (Teva). Broad incumbents are Bayer AG (Consumer Health), Sanofi-Aventis Deutschland GmbH and Haleon plc (Consumer Healthcare).
Does Doppelherz Pharma have an API?
No public API is recorded for Doppelherz Pharma.
What industry is Doppelherz Pharma in?
Doppelherz Pharma's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIAAAA, Primary Care & General Medicine Pharmaceuticals, with a secondary code of HLAIAAAB, Specialty Care Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.